Skip to main content
Canna~Fangled Abstracts

Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models

By December 18, 2020No Comments

doi: 10.1007/978-3-030-57369-0_4.

Affiliations 

Abstract

In recent years, an increasing number of investigations has demonstrated the therapeutic potential of molecules targeting the endocannabinoid system. Cannabinoids of endogenous, phytogenic, and synthetic nature have been assessed in a wide variety of disease models ranging from neurological to metabolic disorders. Even though very few compounds of this type have already reached the market, numerous preclinical and clinical studies suggest that cannabinoids are suitable drugs for the clinical management of diverse pathologies.In this chapter, we will provide an overview of the endocannabinoid system under certain physiopathological conditions, with a focus on neurological, oncologic, and metabolic disorders. Cannabinoids evaluated as potential therapeutic agents in experimental models with an emphasis in the most successful chemical entities and their perspectives towards the clinic will be discussed.

 

Keywords: Cannabinoids, Clinical studies, Endocannabinoid system, Experimental models, Synthetic cannabinoids

References

    1. Abrams DI, Guzman M (2015) Cannabis in cancer care. Clin Pharmacol Ther 97:575–586. https://doi.org/10.1002/cpt.108 – DOI – PubMed
    1. Al-zoubi R, Morales P, Reggio PH (2019) Structural insights into CB1 receptor biased signaling. Int J Mol Sci 20:1837. https://doi.org/10.3390/ijms20081837 – DOI – PMC
    1. Amato G, Khan NS, Maitra R (2019) A patent update on cannabinoid receptor 1 antagonists (2015-2018). Expert Opin Ther Pat 29:261–269. https://doi.org/10.1080/13543776.2019.1597851 – DOI – PubMed – PMC
    1. Andradas C, Caffarel MM, Pérez-Gómez E et al (2011) The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK. Oncogene 30:245–252. https://doi.org/10.1038/onc.2010.402 – DOI – PubMed
    1. Argueta DA, DiPatrizio NV (2017) Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity. Physiol Behav 171:32–39. https://doi.org/10.1016/j.physbeh.2016.12.044 – DOI – PubMed – PMC

Leave a Reply